ANTIBODIES
Contributor Information
- Name Mike Price
- Institute University of Nottingham
Tool Details
- Tool name: Anti-MUC1 [C595 (NCRC48)]
- Alternate names: CD227; KL6; Mucin 1; PEMT
- Clone: C595 (NCRC48)
- Tool type: Antibodies
- Tool sub-type: Primary antibody
- Class: Monoclonal
- Conjugate: Unconjugated
- Reactivity: Human
- Host: Mouse
- Cancer type: Breast cancer; Gynaecologic cancer; Digestive / Gastrointestinal cancer;
- Molecular weight of the target: 122 kDa
- Application: ELISA ; FACS ; IHC ; WB
- Description: MUC1/CA 15-3 is used as a serological clinical marker of breast cancer to monitor response to breast cancer treatment and disease recurrence. Decreased levels over time may be indicative of a positive response to treatment. Conversely, increased levels may indicate disease progression. At an early stage disease, only 21% of patients exhibit high MUC1/CA 15-3 levels, that is why CA 15-3 is not a useful screening test. Most antibodies target the highly immunodominant core peptide domain of 20 amino acid (APDTRPAPGSTAPPAHGVTS) tandem repeats. Some antibodies recognize glycosylated epitopes. Medullary cystic kidney disease 1.
- Immunogen: Urinary MUC-1 mucin (Human)
- Isotype: IgG3
- Research area: Cancer; Cell biology; Genetics
- For Research Use Only
Target Details
- Target: MUC1
- Target molecular weight: 122 kDa
- Target background: MUC1/CA 15-3 is used as a serological clinical marker of breast cancer to monitor response to breast cancer treatment and disease recurrence. Decreased levels over time may be indicative of a positive response to treatment. Conversely, increased levels may indicate disease progression. At an early stage disease, only 21% of patients exhibit high MUC1/CA 15-3 levels, that is why CA 15-3 is not a useful screening test. Most antibodies target the highly immunodominant core peptide domain of 20 amino acid (APDTRPAPGSTAPPAHGVTS) tandem repeats. Some antibodies recognize glycosylated epitopes. Medullary cystic kidney disease 1.
Application Details
- Application: ELISA ; FACS ; IHC ; WB
Handling
- Format: Liquid
- Concentration: 0.9-1.1 mg/ml
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -80°C
- Shipping conditions: Shipping at 4Ă°C
Documentation
Related Tools
References
- • Yew et al. 2013. PLoS One. 8(9):e72637. PMID: 24039787.
- • Epimorphin-induced MET sensitizes ovarian cancer cells to platinum.
- • Guimaraes-Souza et al. 2012. Nephrol Dial Transplant. 27(8):3082-90. PMID: 22287659.
- • In vitro reconstitution of human kidney structures for renal cell therapy.
.svg)
Unit size: 
.svg)
.svg)
